Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TNFAIP8L2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TREM2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
LAT2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
C1QA - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TMEM119 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CD4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SERPINA1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RCSD1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PTGS1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ST8SIA4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CD37 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GPSM3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
APOC2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SAMSN1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
C1QC - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
INPP5D - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
C3AR1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FGL2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CEBPA - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on